Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by HopefulJuanon Oct 16, 2020 5:44pm
106 Views
Post# 31732778

RE:RE:distribution income

RE:RE:distribution incomeThanks for the reply. The distribution income can't have anything to do with CC Pharma distributing APHA weed as it just started in the current quarter. 

Searching German medical cannabis seems to indicate 100,000 registered patients and a central distribution facility. Can any one confirm the role of CC. Could be they are selling cotton swabs to 13000 pharmacies. Not trying to bash, just trying to understand the income number better. Long and strong. Selling at $60

Viking49 wrote: CCPharma which is owned by Aphria is a leading importer and distributor of EU-pharmaceuticals for the German market and distributes products to over 13,000 German pharmacies.


Aphria has now completed all regulatory certifications and are sending cannabis shipments from Aphria 1 to Germany for distribution through the CCPharma distribution network.

The flow has started.  CCPharma network will also be used for distribution of cannabis from Aphria's German grow facility which will complete construction this quarter.

Incremental steps all leading to ongoing revenue growth.

 



<< Previous
Bullboard Posts
Next >>